CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-06 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (right to buy) | −1,716 | 420,148 | ||
| 2021-05-04 | Lee Kevin Chief Executive Officer | Option exercise | +897 | $14.00 | $13K | 255,631 |
| 2021-05-04 | Lee Kevin Chief Executive Officer | Sale | −897 | $32.03 | $29K | 254,734 |
| 2021-05-04 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (right to buy) | −897 | 421,864 | ||
| 2021-05-03 | Lee Kevin Chief Executive Officer | Option exercise | +3,391 | $14.00 | $47K | 258,125 |
| 2021-05-03 | Lee Kevin Chief Executive Officer | Sale | −3,391 | $32.16 | $109K | 254,734 |
| 2021-05-03 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (right to buy) | −3,391 | 422,761 | ||
| 2021-04-30 | Lee Kevin Chief Executive Officer | Option exercise | +30,406 | $14.00 | $426K | 285,140 |
| 2021-04-30 | Lee Kevin Chief Executive Officer | Sale | −3,771 | $29.89 | $113K | 281,369 |
| 2021-04-30 | Lee Kevin Chief Executive Officer | Sale | −26,635 | $30.88 | $822K | 254,734 |
| 2021-04-30 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −30,406 | 426,152 | ||
| 2021-04-29 | Lee Kevin Chief Executive Officer | Option exercise | +6,018 | $14.00 | $84K | 260,752 |
| 2021-04-29 | Lee Kevin Chief Executive Officer | Sale | −4,409 | $30.35 | $134K | 256,343 |
| 2021-04-29 | Lee Kevin Chief Executive Officer | Sale | −1,609 | $30.95 | $50K | 254,734 |
| 2021-04-29 | Lee Kevin Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −6,018 | 456,558 | ||
| 2021-04-28 | Lee Kevin Chief Executive Officer | Option exercise | +22,495 | $14.00 | $315K | 277,229 |
| 2021-04-28 | Lee Kevin Chief Executive Officer | Sale | −6,487 | $30.43 | $197K | 270,742 |
| 2021-04-28 | Lee Kevin Chief Executive Officer | Sale | −14,348 | $31.22 | $448K | 256,394 |
| 2021-04-28 | Lee Kevin Chief Executive Officer | Sale | −1,460 | $32.30 | $47K | 254,934 |
| 2021-04-28 | Lee Kevin Chief Executive Officer | Sale | −200 | $33.35 | $7K | 254,734 |
Page 24 of 26 · 520 trades